IQV Stock Analysis: Buy, Sell, or Hold?
IQV - IQVIA Holdings Inc.
$169.12
-1.56 (-0.91%)
▼
5d:
-5.37%
30d:
-1.65%
90d:
+1.31%
HOLD
LOW Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 05, 2026
0d
Smart Money Distribution
IQV is up 12.8% this week, but smart money is buying puts. Top strike: $165 2026-06-18 with 73 OI. Put ratio: 61% View Scanner →
Strength: 7.5/10
Get Alerted When IQV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: IQV shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: IQV shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$289.56
Based on 7.4% avg growth
INTRINSIC VALUE TODAY
$179.79
5.9% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: IQV is currently trading at $169.12, which is considered fair relative to its 30-day fair value range of $163.26 to $176.89. From a valuation perspective, the stock is trading at a discount (Forward PE: 11.9) compared to its historical average (14.3). Remarkably, the market is currently pricing in an annual earnings decline of 5.9% over the next few years. This pessimistic expectation contrasts with the company's recent 15.0% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, IQV is in a strong uptrend. Immediate support is located at $156.62, while resistance sits at $182.70.
Market Sentiment: IQV has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $228.60 (+35.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, IQV is in a strong uptrend. Immediate support is located at $156.62, while resistance sits at $182.70.
Market Sentiment: IQV has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $228.60 (+35.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$163.26 -
$176.89
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
83.3%
Protect Your Profits
Holding IQV? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 35.2% below Wall St target ($228.60)
- CAUTION: Recommendation downgraded due to -5.4% 5-day decline
Trading Range Analysis
30-Day Trading Range
$163.26 -
$176.89
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$156.63
Resistance Level
$182.70
Current Trend
Strong Uptrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
11.92
Wall Street Target
$228.60
(+35.2%)
Revenue Growth (YoY)
8.4%
Earnings Growth (YoY)
15.0%
Profit Margin
8.3%
Valuation Discount vs History
-5.9% cheaper
PE vs Historical
11.9 vs 14.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-5.9%
(market-implied from PE analysis)
1-Year Target
$159.14
(-6%)
2-Year Target
$149.75
(-12%)
3-Year Target
$140.92
(-17%)
3-Yr Target (if PE normalizes)
(PE: 12→14)
$169.06
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.1, Growth: 10.8%)
$426.00
(+152%)
Base:
(SPY PE: 11.9, Growth: 10.8%)
$230.08
(+36%)
Bear:
(PE: 10.1, Growth: 10.8%)
$195.57
(+16%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (21x PE), but valuation improves significantly next year (12x PE) as earnings recover.
Trailing PE: 20.98 | Current EPS (TTM): $8.06
Bull Case
$327.48
(+94%)
Analyst growth 76.0%, PE expands to 23.1
Base Case
$297.71
(+76%)
Market implied 76.0%, PE stable at 21.0
Bear Case
$115.00
(-32%)
Severe decline -20.0%, PE contracts to 17.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 11.9 to 14.3
Stabilization Target:
$202.89
(+20.0%)
PE Expansion Potential:
+20.0%
Share & Embed Analysis
Last updated: May 18, 2026 4:06 AM ET
Data refreshes hourly during market hours. Next update: 5:06 AM
Data refreshes hourly during market hours. Next update: 5:06 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IQV showing a specific setup today?
Insider Activity (6 Months)
1
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Kevin Hern
SELL
2026-03-16
Ro Khanna
SELL
2026-02-24
Ro Khanna
SELL
2026-01-29
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$613 | 54 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$248 | 53 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$131 | 60 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$261 | 49 HOLD |
Advanced IQV Option Strategies
Professional options setups generated by AI based on today's IQV price and gamma walls.
